|
Gene: TM4SF4 |
Gene summary for TM4SF4 |
Gene summary. |
Gene information | Species | Human | Gene symbol | TM4SF4 | Gene ID | 7104 |
Gene name | transmembrane 4 L six family member 4 | |
Gene Alias | ILTMP | |
Cytomap | 3q25.1 | |
Gene Type | protein-coding | GO ID | GO:0008150 | UniProtAcc | P48230 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
7104 | TM4SF4 | HTA11_2487_2000001011 | Human | Colorectum | SER | 3.73e-17 | 1.16e+00 | -0.1808 |
7104 | TM4SF4 | HTA11_411_2000001011 | Human | Colorectum | SER | 5.61e-03 | 7.17e-01 | -0.2602 |
7104 | TM4SF4 | NAFLD1 | Human | Liver | NAFLD | 2.43e-09 | -1.01e+00 | -0.04 |
7104 | TM4SF4 | S41 | Human | Liver | Cirrhotic | 4.90e-21 | -1.57e+00 | -0.0343 |
7104 | TM4SF4 | S42 | Human | Liver | HCC | 4.42e-14 | -1.58e+00 | -0.0103 |
7104 | TM4SF4 | S43 | Human | Liver | Cirrhotic | 8.12e-35 | -7.61e-01 | -0.0187 |
7104 | TM4SF4 | S44 | Human | Liver | HCC | 1.86e-11 | -1.56e+00 | -0.0083 |
7104 | TM4SF4 | HCC1_Meng | Human | Liver | HCC | 1.53e-113 | -9.07e-01 | 0.0246 |
7104 | TM4SF4 | HCC2_Meng | Human | Liver | HCC | 3.14e-92 | -1.61e+00 | 0.0107 |
7104 | TM4SF4 | cirrhotic2 | Human | Liver | Cirrhotic | 1.49e-04 | 1.75e-01 | 0.0201 |
7104 | TM4SF4 | cirrhotic3 | Human | Liver | Cirrhotic | 2.42e-05 | -3.72e-01 | 0.0215 |
7104 | TM4SF4 | p6 | Human | Liver | Cyst | 1.20e-28 | -1.82e+00 | -0.0218 |
7104 | TM4SF4 | HCC1 | Human | Liver | HCC | 1.09e-13 | 1.46e+00 | 0.5336 |
7104 | TM4SF4 | HCC2 | Human | Liver | HCC | 1.52e-19 | 3.89e+00 | 0.5341 |
7104 | TM4SF4 | HCC5 | Human | Liver | HCC | 7.74e-55 | -1.34e+00 | 0.4932 |
7104 | TM4SF4 | Pt13.a | Human | Liver | HCC | 5.10e-30 | -5.06e-01 | 0.021 |
7104 | TM4SF4 | Pt13.b | Human | Liver | HCC | 1.87e-29 | -4.58e-01 | 0.0251 |
7104 | TM4SF4 | Pt13.c | Human | Liver | HCC | 1.59e-33 | -1.23e+00 | 0.0076 |
7104 | TM4SF4 | Pt14.a | Human | Liver | HCC | 9.15e-08 | -6.46e-01 | 0.0169 |
7104 | TM4SF4 | Pt14.b | Human | Liver | HCC | 3.17e-07 | -5.58e-01 | 0.018 |
Page: 1 2 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00310993 | Liver | NAFLD | regeneration | 35/1882 | 198/18723 | 6.67e-04 | 8.61e-03 | 35 |
GO:003109911 | Liver | Cirrhotic | regeneration | 71/4634 | 198/18723 | 3.02e-04 | 2.65e-03 | 71 |
GO:00310992 | Liver | HCC | regeneration | 107/7958 | 198/18723 | 6.67e-04 | 4.12e-03 | 107 |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TM4SF4 | SNV | Missense_Mutation | novel | c.416N>G | p.Asp139Gly | p.D139G | P48230 | protein_coding | deleterious(0.02) | possibly_damaging(0.665) | TCGA-RD-A8N9-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Chemotherapy | epirubicin | SD |
TM4SF4 | SNV | Missense_Mutation | c.401G>T | p.Gly134Val | p.G134V | P48230 | protein_coding | deleterious(0) | probably_damaging(0.967) | TCGA-VQ-A925-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |